Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy
The ALRCaN Global webinar, “Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy,” is set for Friday, May 15, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Mark Litzow, this session explores the evolving treatment landscape and clinical integration of immunotherapeutic agents into frontline regimens for […]